• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    崇

    崇城大学

    Sojo University
    院校EST. 1949
    2,572论文总数
    4.7万引用总数

    Sojo University (崇城大学, Sōjō daigaku) is a private university in Nishi-ku, Kumamoto, Japan. The predecessor of the school was founded in 1949, and it was chartered as a junior college in 1965. After becoming a four-year college in 1967, it adopted the present name in 2000. In 2001 Japanese Course for foreign students was opened. In 2004 Graduate School of Art was established, division of Fine Art Master Course and division of Design Master Course was opened and applied Life Science Master Course and applied Life Science Doctoral Course opened..

    论文量&引用量时间轴

    机构学者

    排序
    Masaki Otagiri
    Masaki Otagiri
    Faculty of Pharmaceutical Sciences, Sojo University
    论文:207引用:0H-index:0
    Toru Maruyama
    Toru Maruyama
    Department of Biopharmaceutics Graduate School of Pharmaceutical Sciences, Kumamoto University
    论文:130引用:0H-index:0
    Toshihiro Nohara
    Toshihiro Nohara
    Faculty of Pharmaceutical Sciences, Sojo University
    论文:105引用:0H-index:0
    Hiroshi Maeda
    Hiroshi Maeda
    Tohoku University
    论文:95引用:0H-index:0
    Jun Fang
    Jun Fang
    Research Institute of Drug Delivery Sciences, Sojo University
    论文:85引用:0H-index:0
    Keishi Yamasaki
    Keishi Yamasaki
    Faculty of Pharmaceutical Sciences, Kumamoto University
    论文:83引用:0H-index:0
    Fumitoshi Hirayama
    Fumitoshi Hirayama
    Faculty of Pharmaceutical Sciences, Sojo University
    论文:80引用:0H-index:0
    Yoko Matsumoto
    Yoko Matsumoto
    Sojo University
    论文:80引用:0H-index:0
    Ryuichi Ueoka
    Ryuichi Ueoka
    Division of Applied Life ScienceGraduate School of Engineering, Sojo University
    论文:79引用:0H-index:0

    论文(2572)

    年份
    起
    –
    止
    排序
    1Antitumor Efficacy and Reduced Systemic Toxicity of Palmitic Acid-Modified Pirarubicin Nanoparticles in Mice
    Kenji Tsukigawa, Takashi Hasegawa, Kindness Lomotey Commey,Shuhei Imoto,Koji Nishi,Masaki Otagiri,Keishi Yamasaki

    Pirarubicin (THP) is a potent anthracycline anticancer agent; however, its clinical use is limited by nonselective tissue distribution and systemic toxicity. This study aimed to evaluate whether palmitic acid-modified THP nanoparticles (Pal-THP nanoparticles) could improve the in vivo therapeutic profile of THP. Pal-THP nanoparticles stabilized by albumin as a formulation stabilizer were prepared by antisolvent precipitation. Antitumor efficacy, biodistribution, and drug forms (intact Pal-THP and the free THP released from Pal-THP) were evaluated in colon 26 tumor-bearing mice following intravenous administration. Acute systemic and hemolytic toxicity were assessed relative to THP. Pal-THP nanoparticles significantly suppressed tumor growth compared with the control group, without inducing body weight loss, whereas THP exhibited a tendency toward tumor suppression but did not reach statistical significance versus control at an equivalent dose. While the absolute tumor accumulation of Pal-THP nanoparticles was limited, it was significantly higher than that of THP. Importantly, there was efficient conversion of Pal-THP to free THP in tumor tissue, which is consistent with the presence of an acid‑labile hydrazone linkage. Pal-THP nanoparticles also markedly attenuated acute systemic and hemolytic toxicity, in contrast to THP, under the present experimental conditions. Pal-THP nanoparticles altered the in vivo fate of THP through tumor accumulation and tumor-localized conversion to free THP. This resulted in effective tumor suppression and a significant reduction in toxicity compared to THP in mice. Thus, this formulation strategy represents a promising approach for improving the therapeutic index of chemotherapy using THP and other anthracyclines.

    2026Cancer Chemotherapy and Pharmacology(2026)引用:31
    引用
    AI阅读
    加入学术空间
    2HEAT-TRANSFER ENHANCEMENT ON THE FLAT PLATE INSTALLED IN A PULSATING DUCT FLOW UNDER NON-UNIFORM INFLOW CONDITIONS FOR LAMINAR FLOW REGIME IN TIME-AVERAGED FLOW RATE
    Raiki Katoh, Hironori Saitoh

    This study deals with the feasibility of active temperature control with a pulsating flow for various industrial applications such as thermal devices and many kinds of manufacturing for further improvements of their performance and product quality. The authors focus on the heat-transfer characteristics on the flat plate installed in a pulsating duct flow. Experiments aiming to make clear the effect of flow conditions (time-averaged flow rate, pulsating frequency and amplitude) on heattransfer in pulsating flows with two different flow-rate fluctuation modes (continuous sinusoidal wave and intermittent pulse wave) have been conducted. In the past experiments, regardless of pulsation mode, no difference in heat-transfer between steady flow and pulsating flow was obtained when flow was supplied with uniform velocity distribution at the inlet. Heat-transfer enhancement by flow pulsation was confirmed when flow was supplied with non-uniform velocity distribution at the inlet, regardless of pulsation mode. This tendency was confirmed in both flow regimes of laminar and turbulent flows. To elucidate the mechanisms of such heat-transfer enhancement especially for the laminar flow regime in cases with non-uniform inflow conditions, local velocity measurements of its temporal fluctuation and time-averaged value in the channel-width direction were carried out with a hot-wire anemometer. Measurements were conducted for four cross sections in the flow direction. The results showed that the time-averaged velocity profile changed along with the flow direction from a non-uniform to a uniform one. This tendency was observed more clearly with increasing pulsating frequency.

    2026JOURNAL OF ENHANCED HEAT TRANSFER(2026)引用:11
    引用
    AI阅读
    加入学术空间
    3Space Flight of Liquid Rotating Detonation Engine Using Sounding Rocket S-520-34
    Tomoki Sato,Ken Matsuoka,Noboru Itouyama, Masaaki Yasui,Koichi Matsuyama, Yuichiro Ide,Kotaro Nakata, Yamato Suzuki, Ryoto Ishibashi, Sota Suzuki,Jiro Kasahara,Akira Kawasaki,

    One of the most important goals in aerospace engineering applications is the creation of new "flyable" systems. In a flight demonstration using the sounding rocket S-520-34, we show the first successful operation of a bipropellant cylindrical rotating detonation engine using liquid ethanol and liquid nitrous oxide, Detonation Engine System 2 (DES2), in a space environment. From the pressure and temperature histories, the combustion was finished before all propellants were consumed because nitrogen was supplied earlier than the ideal depletion time due to spin stabilization of the sounding rocket. Therefore, the combustion pressure decreased from the nitrogen-supply start time. The short-time Fourier transform result indicated that the deflagration mode, two-wave mode, and single-wave mode occurred in sequence. This was attributed to the locally lower liquid temperatures, wall temperature, and mixture ratio at ignition near the wall, where the rotating detonation wave propagated. A comparison of the filling mass and consumption indicated that the mass flow rate estimated using control surface theory reflects an actual phenomenon. As for the propulsive performance, the experimental characteristic exhaust velocity was almost the same as the ideal value. Moreover, a specific impulse efficiency of more than 90% was achieved throughout the rotating detonation engine operation.

    2026JOURNAL OF SPACECRAFT AND ROCKETS(2026)引用:2
    引用
    AI阅读
    加入学术空间
    4Hepatic Supersulfides Attenuate Acetaminophen-Induced Liver Injury Via Enhanced Detoxification and Anti-Inflammatory Mechanisms
    Chunyu Guo, Touya Toyomoto,Hiroyasu Tsutsuki,Yukio Fujiwara,Yoshihiro Komohara,Tianli Zhang, Hina Honda, Stephen Lindahl, Takuro Niidome,Jun Fang,Ming Xian,Tomohiro Sawa

    Acetaminophen (APAP) is a widely used antipyretic and analgesic agent; however, overdose can lead to hepatotoxicity and, in severe cases, acute liver failure. Development of therapeutics that mitigate APAP-induced liver injury is essential to prevent progression to hepatic failure. Upon overdose, APAP is metabolized in the liver to the highly reactive electrophile N-acetyl-p-benzoquinone imine (NAPQI), which induces hepatocellular damage. Glutathione (GSH), a key intracellular nucleophile, exists partially in a modified form as glutathione hydropersulfide (GSSH), which exhibits enhanced nucleophilicity and functions as a supersulfide. While detoxification of NAPQI via GSH conjugation is well established, the role of GSSH in NAPQI detoxification has remained unknown. In this study, we investigated the protective role of hepatic supersulfides against APAP-induced liver injury using a murine model. Utilizing a newly developed tandem mass spectrometry technique, we demonstrated that supersulfides form conjugates with NAPQI, which are subsequently excreted in the urine. Moreover, administration of supersulfide donors, such as N-acetylcysteine (NAC) tetrasulfide and thioglucose tetrasulfide, elevated hepatic supersulfide levels and significantly attenuated APAP-induced liver injury. Notably, the protective effects of these donors surpassed those of conventional NAC treatment. Our findings suggest that the hepatoprotective effects of supersulfide donors involve not only enhanced detoxification of NAPQI, thereby reducing hepatocellular damage, but also suppression of inflammation. These results highlight the therapeutic potential of targeting hepatic supersulfides in the treatment of APAP overdose.

    2026Redox biology(2026)引用:1
    引用
    AI阅读
    加入学术空间
    5Preparation and Evaluation of Hydrophobin-Pirarubicin Glucosamine-Containing Nanoparticles As an Anticancer Formulation.
    Jennyfer Hernández-Alcántara,Hideaki Nakamura,Kenji Tsukigawa,Keishi Yamasaki, Ryota Uchimura,Akihiko Kuniyasu,Masaki Otagiri, Josefina Valadez-García,Makoto Anraku, Keiko Shirai

    Pirarubicin nanoparticles were prepared using the amphiphilic protein hydrophobin with a particle size of 84.13 ± 2.23 nm as a carrier. Furthermore, glucosamine was incorporated into the formulation to develop glucosamine-containing pirarubicin hydrophobin nanoparticles with a particle size of 111.41 ± 3.62 nm. The anticancer effects of the nanoparticles were evaluated in C26 cells and tumor-bearing mice, compared with pirarubicin alone. The evaluation in C26 cells revealed that nanoparticles with added glucosamine exhibited significantly more vigorous anticancer activity than nanoparticles alone. Moreover, glucosamine nanoparticles demonstrated a considerably higher tumor-site antitumor effect in tumor-bearing mice than nanoparticles and pirarubicin. These results suggest that glucosamine-containing pirarubicin hydrophobin nanoparticles are highly efficient and selective, holding promise for future clinical applications.

    2026International journal of biological macromolecules(2026)引用:1
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2572 篇论文

    合作机构(100)

    熊本大学合作论文 610
    九州大学合作论文 158
    福冈大学合作论文 111
    东海大学合作论文 104
    德岛大学合作论文 51
    东京大学合作论文 47
    萨格大学合作论文 39
    长崎大学合作论文 37
    东北大学(日本)合作论文 36
    庆应义塾大学合作论文 31

    机构统计